About this Webinar
Hidradenitis Suppurativa: Opportunity Analysis and Forecasts to 2028
Speakers
Michael Breen, PhD
Michael Breen, PhD, is the Director of Infectious Diseases and Ophthalmology at GlobalData in Boston. He has over eight years of experience in market analysis, business intelligence, and providing strategic insight for the pharmaceutical industry. Prior to his current role, he was a Senior Analyst for Decision Resources Group, where he gained extensive experience writing in-depth reports and developing forecasts for a variety of indications, including rare and infectious diseases and vaccines.
Michael has a BA in biology and biochemistry from Hunter College, and a PhD in biochemistry from Boston University School of Medicine
Vikesh Devlia, PhD
Vikesh Devlia, PhD, is an Analyst for the Immunology Therapy team at GlobalData in London. He is currently responsible for providing expert insight and detailed reports in the Immunology space with an emphasis on disease market and therapy forecasting. He has over seven years of research experience in immunology and in academic and pharmaceutical laboratories at the Anthony Nolan Research Institute, University College London, and King’s College London. At UCL and the Anthony Nolan Research Institute, he earned his PhD investigating immune reconstitution in cord blood transplantation. Prior to his PhD he worked in clinical research and investigated the presence of biomarkers on monocytic cells before and after treatment with Humira in arthritic patients.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


